Possible predictive biomarkers for tumor reaction to mTOR inhibitors, as happen to be explained in glioblastoma, breast and prostate most cancers cells, may be the differential expression of mTOR pathway proteins, PTEN, AKT, and S6.[one] Thus, this information relies on preclinical assays, based upon in vitro cultured tumor mobile strains, https://steveni207ydh0.oneworldwiki.com/user